Edition:
United States

Dova Pharmaceuticals Inc (DOVA.OQ)

DOVA.OQ on NASDAQ Stock Exchange Global Market

21.72USD
4:00pm EDT
Change (% chg)

$-1.02 (-4.49%)
Prev Close
$22.74
Open
$22.75
Day's High
$22.75
Day's Low
$21.54
Volume
55,859
Avg. Vol
90,784
52-wk High
$35.52
52-wk Low
$20.56

Chart for

About

Dova Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on acquiring, developing and commercializing drug candidates. The Company’s initial focus is on thrombocytopenia, a disorder characterized by a low blood platelet count. The Company is developing avatrombopag for treatment of thrombocyt... (more)

Overall

Beta: --
Market Cap(Mil.): $654.32
Shares Outstanding(Mil.): 28.19
Dividend: --
Yield (%): --

Financials

  DOVA.OQ Industry Sector
P/E (TTM): -- 97.68 30.58
EPS (TTM): -1.96 -- --
ROI: -82.56 3.30 12.84
ROE: -98.78 2.30 15.02

BRIEF-Dova Pharmaceuticals Announces Proposed Offering Of Common Stock

* DOVA PHARMACEUTICALS, INC. ANNOUNCES PROPOSED OFFERING OF COMMON STOCK

Feb 20 2018

BRIEF-Dova Pharma Files For Offering Of Up To 2.5 Mln Shares

* DOVA PHARMACEUTICALS INC FILES FOR OFFERING OF UP TO 2.5 MILLION SHARES OF CO'S COMMON STOCK - SEC FILING Source text for Eikon: (http://bit.ly/2FgTI9o) Further company coverage:

Feb 20 2018

Earnings vs. Estimates